Position in TECH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$39,893,511
New position
Shares Held
564,664
first reported quarter
Ownership
0.360%
of shares outstanding
% of Portfolio
8.57%
of 13F equity value
Holder Rank
#53
of 593 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Derivatives in TECH
reported options exposure · as of Jun 30, 2026CallValue
$9,085,590
CallShares
128,600
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Decagon Asset Management LLP holds $39,893,511 across 2 Biotechnology names. TECH ranks #1 (100.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
This page
|
564,664 | $39,893,511 | |
| 2 | CDT |
CDT Equity Inc.
|
400,000 | $0 |
All Filings in TECH
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,085,590 | 128,600 | Call | Sole | 2026-08-14 | |
| 2026-06-30 | $39,893,511 | 564,664 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||